Document Detail


In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.
MedLine Citation:
PMID:  20472504     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Immune reconstitution after HAART is incomplete, but no widely accepted method to quantify subclinical immune deficiency is available. We immunized 9 HIV-negative subjects and 29 HIV-infected patients with CD4>/=450 cells/microL and undetectable HIV RNA levels with 2 doses of diphtheria/tetanus toxoid (TT) and KLH, a presumed neoantigen. We quantified the response by lymphoproliferative assay, delayed-type hypersensitivity (DTH), and antibody titers up to 59days after enrollment. We assessed T cell proliferative capacity using anti-Vbeta3 and anti-Vbeta5 antibody stimulation, which we herein show induced predominant proliferation of naïve T cells. Subjects with detectable responses to KLH tended to exhibit greater proliferative responses to anti-Vbeta3/Vbeta5 stimulation; no such pattern was seen with response to TT. Several measures of in vitro T cell proliferative capacity correlated significantly with DTH and antibody responses to KLH, but not with TT responses; this association was independent of naïve T cell numbers. Our results indicate that naïve T cell proliferation predicts response to neo-, but not recall antigens, and suggest that it may be a meaningful reflection of in vivo immune competence in HIV-infected persons.
Authors:
Benigno Rodriguez; Hernan Valdez; Christoph G Lange; Robert Asaad; Kathy Medvik; Scott F Sieg
Related Documents :
16142674 - Immune reconstitution syndrome due to bacillus calmette-guérin after initiation of ant...
18753204 - Evidence for protection against chronic hepatitis c virus infection in chimpanzees by i...
1614464 - Prophylactic intravenous administration of standard immune globulin as compared with co...
7719154 - Anti-cd4 activity in circulating immune complexes in hiv-infected patients.
15778114 - Ethical issues in hiv.
9058674 - Osteonecrosis and human immunodeficiency virus infection.
Publication Detail:
Type:  In Vitro; Journal Article     Date:  2010-05-15
Journal Detail:
Title:  Clinical immunology (Orlando, Fla.)     Volume:  136     ISSN:  1521-7035     ISO Abbreviation:  Clin. Immunol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-06     Completed Date:  2010-08-30     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  100883537     Medline TA:  Clin Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  400-8     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Case Western Reserve University Center for AIDS Research, Cleveland, OH 44106-5083, USA. rodriguez.benigno@clevelandactu.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antibody Formation
Antigens / administration & dosage
Antiretroviral Therapy, Highly Active
Case-Control Studies
Cell Proliferation
Female
HIV Infections / drug therapy,  immunology*,  therapy
Hemocyanin / administration & dosage
Humans
Hypersensitivity, Delayed
Immunization
Immunization Schedule
Immunocompetence
Lymphocyte Activation
Male
Middle Aged
T-Lymphocytes / immunology*,  pathology
Tetanus Toxoid / administration & dosage
Grant Support
ID/Acronym/Agency:
P01 AI076174-01A1/AI/NIAID NIH HHS; P30 AI036219-15S18854/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Antigens; 0/Tetanus Toxoid; 0/keyhole-limpet hemocyanin; 9013-72-3/Hemocyanin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pi...
Next Document:  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/veloca...